BRK.B
45
-2
COST
48
-3
CTAS
39
-3
CPB
37
-2
AMT
29
-4
AVB
35
-7
ADP
51
-4
BLK
52
-6
BDX
57
-2
ALLE
46
-4
CME
49
-4
CVS
41
-2
AVGO
40
-5
DE
42
-3
CB
62
-5
AMG
75
-4
AME
69
-5
AMP
61
-3
DOV
63
-6
AEP
64
-3
BRK.B
45
-2
COST
48
-3
CTAS
39
-3
CPB
37
-2
AMT
29
-4
AVB
35
-7
ADP
51
-4
BLK
52
-6
BDX
57
-2
ALLE
46
-4
CME
49
-4
CVS
41
-2
AVGO
40
-5
DE
42
-3
CB
62
-5
AMG
75
-4
AME
69
-5
AMP
61
-3
DOV
63
-6
AEP
64
-3
Financhill
Back

Virtus AllianzGI Dividend Interest & Premium Strategy Fund Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Buy
58

NFJ
Virtus AllianzGI Dividend Interest & Premium Strategy Fund

Last Price:
$12.86
Seasonality Move:
0.43%
Sell
39

ZBIO
Zenas BioPharma, Inc.

Last Price:
$36.25
Seasonality Move:
-0.81%
Buy
58
Virtus AllianzGI Dividend Interest & Premium Strategy Fund (NFJ) is a Buy

Is Virtus AllianzGI Dividend Interest & Premium Strategy Fund a Buy, Sell or Hold?

  • The current Virtus AllianzGI Dividend Interest & Premium Strategy Fund [NFJ] share price is $12.89. The Score for NFJ is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • NFJ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $36.31. The Score for ZBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NFJ Stock Price Chart

What is Virtus AllianzGI Dividend Interest & Premium Strategy Fund's stock price today?

  • The Virtus AllianzGI Dividend Interest & Premium Strategy Fund share price today is $12.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NFJ is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $36.31
    The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

NFJ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 50.63 Buy
Chaikin Money Flow: 314319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.75 - 13.09) Sell
Bollinger Bands (100): (12.73 - 13.05) Sell

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.68 Buy
Relative Strength Index (14 RSI): 47.21 Sell
Chaikin Money Flow: 289999 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.8 - 41.14) Sell
Bollinger Bands (100): (19.01 - 36.29) Buy

NFJ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.86 Buy
20-day SMA: 12.93 Sell
50-day SMA: 12.87 Buy
200-day SMA: 12.48 Buy
8-day EMA: 12.88 Buy
20-day EMA: 12.88 Buy
50-day EMA: 12.88 Buy
200-day EMA: 12.69 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.86 Sell
20-day SMA: 38.54 Sell
50-day SMA: 35.24 Buy
200-day SMA: 19.17 Buy
8-day EMA: 35.64 Buy
20-day EMA: 24.68 Buy
50-day EMA: 12.87 Buy
200-day EMA: 3.71 Buy

Virtus AllianzGI Dividend Interest & Premium Strategy Fund Earnings Growth & NFJ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.15 per share.

Virtus AllianzGI Dividend Interest & Premium Strategy Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):